How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?

Giersing BK., Porter CK., Kotloff K., Neels P., Cravioto A., MacLennan CA.

DOI

10.1016/j.vaccine.2019.03.036

Type

Journal article

Publisher

Elsevier BV

Publication Date

2019-08-01T00:00:00+00:00

Volume

37

Pages

4778 - 4783

Total pages

5

Permalink More information Close